Journey Medical (DERM) Cash from Investing Activities (2020 - 2023)
Journey Medical's (DERM) quarterly Cash from Investing Activities came in at -$5.0 million in Q1 2023, up 75.0% YoY from -$2.9 million in Q1 2022, and up 75.0% on a QoQ basis from -$20.0 million in Q1 2022.
Journey Medical (DERM) Cash from Investing Activities (2020 - 2023) Analysis & Trends
Journey Medical (DERM) has 4 years of Cash from Investing Activities data on file, last reported at -$5.0 million in Q1 2023.
- Quarterly Cash from Investing Activities rose 75.0% year-over-year to -$5.0 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was -$5.0 million (up 75.0% YoY) and the FY2024 annual result came in at -$15.0 million, down 200.0% from the prior year.
- Cash from Investing Activities improved to -$5.0 million in Q1 2023, from -$20.0 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$200000.0 in Q4 2020 to a low of -$20.0 million in Q1 2022.
- A 4-year average of -$6.6 million and a median of -$3.1 million in 2021 frame the typical range for Cash from Investing Activities.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities slumped 500.0% — and 2023, when it jumped 75.0%.
- Tracing DERM's Cash from Investing Activities over 4 years: stood at -$200000.0 in 2020, then tumbled by 500.0% to -$1.2 million in 2021, then sank by 1566.67% to -$20.0 million in 2022, then jumped by 75.0% to -$5.0 million in 2023.
- The last three Cash from Investing Activities figures came in at -$5.0 million (Q1 2023), -$20.0 million (Q1 2022), and -$1.2 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Journey Medical | 205.52 Mn | 179.87 Mn | 12.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -5.00 Mn |
| Mar 31, 2023 | -5.00 Mn |
| Mar 31, 2022 | -20.00 Mn |
| Mar 31, 2022 | -20.00 Mn |
| Dec 31, 2021 | -1.20 Mn |
| Dec 31, 2021 | -1.20 Mn |
| Dec 31, 2020 | -200,000.00 |
| Dec 31, 2020 | -200,000.00 |